A recent study reported transcriptional reprogramming in BRCA1-deficient ovarian cancer cells, which leads to cell-intrinsic inflammation through activation of stimulator of IFN genes (STING; ref. 56). The gene discussed is STING1; the disease is ovarian cancer.